Search PDMR transactions

Notifier
Name of person with notification obligation
Karl Martin Erik Åmark
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Karl Martin Erik Åmark
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xbrane Biopharma AB
Issuer´s LEI code
5493008DKD05APTKQO39
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xbrane Biopharma XB SE0007789409 Acquisition 8,000 Quantity 32.85 SEK 07/09/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Disposal 8,000 Quantity 34.05 SEK 05/09/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xbrane Biopharma XB SE0007789409 Acquisition 07/09/2023 NASDAQ STOCKHOLM AB 8,000 (Quantity) 32.85 SEK
Xbrane Biopharma AB SE0007789409 Disposal 05/09/2023 NASDAQ STOCKHOLM AB 8,000 (Quantity) 34.05 SEK
<< Back